Clinical Trials Logo

Clinical Trial Summary

The term exercise-induced bronchospasm (EIB) describes acute, transient airway narrowing that occurs during, and most often after, exercise. Manifestations of EIB can range from mild impairment of performance to severe bronchospasm and respiratory failure. The pathogenesis of EIB remains controversial and the role of airway inflammation has not yet been definitively characterized. We plan on comparing markers of inflammation in asthmatic participants with and without EIB at baseline and after bronchoprovocation with eucapnic voluntary hyperventilation testing (EVH). We also will collect demographic information as well as information about asthma control and exercise habits.


Clinical Trial Description

At Visit 1, participants will complete questionnaires about demographics, asthma control (if asthmatic) and exercise habits. The participants will have baseline spirometry performed, and skin prick testing for allergies. Skin testing is important as it can influence the level of exhaled nitric oxide and hence we would like to adjust our results for the presence of allergies. Subsequently, volunteers will undergo sputum induction and then have peripheral blood drawn for microRNA analysis. MicroRNA's are single-stranded RNA molecules of about 21-23 nucleotides in length regulating gene expression. Patterns of MicroRNA expression have been linked to heart disease and cancer. Similar patterns have not been identified in exercise-induced asthma. In total, including time for questions and recovery, the time for Visit 1 will be approximately 3 hours. At Visit 2, which will occur 24 hours to 7 days after Visit 1 in order to minimize risk of asthma exacerbation, the participants will again have baseline spirometry. Baseline exhaled nitric oxide will be performed. Eucapnic Voluntary hyperventilation testing will then be performed. They then will have a second exhaled nitric oxide quantification, will undergo sputum induction and then have peripheral blood drawn for microRNA analysis, all occurring after EVH testing. In total, including time for questions and recovery, the time for Visit 2 will be approximately 2 hours. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00701025
Study type Observational
Source Ohio State University
Contact
Status Completed
Phase
Start date April 2008
Completion date February 2011

See also
  Status Clinical Trial Phase
Withdrawn NCT00375232 - Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes N/A
Completed NCT00085774 - Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma Phase 3
Withdrawn NCT03610932 - Vitamin C & Exercise Induced Bronchoconstriction (EIB) N/A
Completed NCT00268723 - Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB Phase 3
Withdrawn NCT00662779 - Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB) Phase 3